Skip Nav Destination
Human ICOS deficiency abrogates the germinal center reaction and provides a monogenic model for common variable immunodeficiency
Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study
Dose-escalated CHOP plus etoposide (MegaCHOEP) followed by repeated stem cell transplantation for primary treatment of aggressive high-risk non-Hodgkin lymphoma
Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation
Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD
Quantitative PCR on 5 genes reliably identifies CTCL patients with 5% to 99% circulating tumor cells with 90% accuracy
Minimal molecular response in polycythemia vera patients treated with imatinib or interferon alpha
Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation
Flow cytometric detection of circulating myeloma cells before transplantation in patients with multiple myeloma: a simple risk stratification system
Issue Archive
Table of Contents
INSIDE BLOOD
REVIEW ARTICLES
CLINICAL TRIALS AND OBSERVATIONS
Human ICOS deficiency abrogates the germinal center reaction and provides a monogenic model for common variable immunodeficiency
Clinical Trials & Observations
Klaus Warnatz,Lukas Bossaller,Ulrich Salzer,Andrea Skrabl-Baumgartner,Wolfgang Schwinger,Mirjam van der Burg,Jacques J. M. van Dongen,Marzena Orlowska-Volk,Rolf Knoth,Anne Durandy,Ruth Draeger,Michael Schlesier,Hans Hartmut Peter,Bodo Grimbacher
Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study
Clinical Trials & Observations
Sylvain Choquet,Veronique Leblond,Raoul Herbrecht,Gérard Socié,Anne-Marie Stoppa,Peter Vandenberghe,Alain Fischer,Franck Morschhauser,Gilles Salles,Walter Feremans,Etienne Vilmer,Marie-Noelle Peraldi,Philippe Lang,Yvon Lebranchu,Eric Oksenhendler,Jeanne Luce Garnier,Thierry Lamy,Arnaud Jaccard,Augustin Ferrant,Fritz Offner,Olivier Hermine,Anne Moreau,Samira Fafi-Kremer,Patrice Morand,Lucienne Chatenoud,Nathalie Berriot-Varoqueaux,Loïc Bergougnoux,Noel Milpied
Dose-escalated CHOP plus etoposide (MegaCHOEP) followed by repeated stem cell transplantation for primary treatment of aggressive high-risk non-Hodgkin lymphoma
Clinical Trials & Observations
Bertram Glass,Marita Kloess,Martin Bentz,Günter Schlimok,Wolfgang E. Berdel,Alfred Feller,Lorenz Trümper,Markus Loeffler,Michael Pfreundschuh,Norbert Schmitz,for the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL)
Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation
Clinical Trials & Observations
Dao-Pei Lu,Lujia Dong,Tong Wu,Xiao-Jun Huang,Mei-Jie Zhang,Wei Han,Huan Chen,Dai-Hong Liu,Zhi-Yong Gao,Yu-Hong Chen,Lan-Ping Xu,Yao-Chen Zhang,Han-Yun Ren,Dan Li,Kai-Yan Liu
Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD
Clinical Trials & Observations
Daniel R. Couriel,Chitra Hosing,Rima Saliba,Elizabeth J. Shpall,Paolo Anderlini,Beverly Rhodes,Veronica Smith,Issa Khouri,Sergio Giralt,Marcos de Lima,Yvonne Hsu,Shubhra Ghosh,Joyce Neumann,Borje Andersson,Muzzafar Qazilbash,Sharon Hymes,Stella Kim,Richard Champlin,Michele Donato
ERRATA
GENE THERAPY
Correction of canine X-linked severe combined immunodeficiency by in vivo retroviral gene therapy
Suk See Ting–De Ravin,Douglas R. Kennedy,Nora Naumann,Jeffrey S. Kennedy,Uimook Choi,Brian J. Hartnett,Gilda F. Linton,Narda L. Whiting-Theobald,Peter F. Moore,William Vernau,Harry L. Malech,Peter J. Felsburg
HEMATOPOIESIS
Acceleration of mesoderm development and expansion of hematopoietic progenitors in differentiating ES cells by the mouse Mix-like homeodomain transcription factor
Stephen Willey,Angel Ayuso-Sacido,Hailan Zhang,Stuart T. Fraser,Kenneth E. Sahr,Matthew J. Adlam,Michael Kyba,George Q. Daley,Gordon Keller,Margaret H. Baron
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
IMMUNOBIOLOGY
Requirement of homotypic NK-cell interactions through 2B4(CD244)/CD48 in the generation of NK effector functions
Kyung-Mi Lee,John P. Forman,Megan E. McNerney,Susan Stepp,Sumalatha Kuppireddi,Dustin Guzior,Yvette E. Latchman,Mohamed H. Sayegh,Hideo Yagita,Chul-Kyu Park,Seog Bae Oh,Christoph Wülfing,John Schatzle,Porunelloor A. Mathew,Arlene H. Sharpe,Vinay Kumar
Quantitative PCR on 5 genes reliably identifies CTCL patients with 5% to 99% circulating tumor cells with 90% accuracy
Clinical Trials & Observations
Michael Nebozhyn,Andrey Loboda,Laszlo Kari,Alain H. Rook,Eric C. Vonderheid,Stuart Lessin,Carole Berger,Richard Edelson,Calen Nichols,Malik Yousef,Lalitha Gudipati,Meiling Shang,Michael K. Showe,Louise C. Showe
Novel stabilin-1 interacting chitinase-like protein (SI-CLP) is up-regulated in alternatively activated macrophages and secreted via lysosomal pathway
Julia Kzhyshkowska,Srinivas Mamidi,Alexei Gratchev,Elisabeth Kremmer,Christina Schmuttermaier,Liis Krusell,Georg Haus,Jochen Utikal,Kai Schledzewski,Joachim Scholtze,Sergij Goerdt
Impact of vaccine-induced mucosal high-avidity CD8+CTLs in delay of AIDS viral dissemination from mucosa
Igor M. Belyakov,Vladimir A. Kuznetsov,Brian Kelsall,Dennis Klinman,Marcin Moniuszko,Michael Lemon,Phillip D. Markham,Ranajit Pal,John D. Clements,Mark G. Lewis,Warren Strober,Genoveffa Franchini,Jay A. Berzofsky
NEOPLASIA
AML1-ETO rapidly induces acute myeloblastic leukemia in cooperation with the Wilms tumor gene, WT1
Sumiyuki Nishida,Naoki Hosen,Toshiaki Shirakata,Keisuke Kanato,Masashi Yanagihara,Shin-ichi Nakatsuka,Yoshihiko Hoshida,Tsutomu Nakazawa,Yukie Harada,Naoya Tatsumi,Akihiro Tsuboi,Manabu Kawakami,Yoshihiro Oka,Yusuke Oji,Katsuyuki Aozasa,Ichiro Kawase,Haruo Sugiyama
Minimal molecular response in polycythemia vera patients treated with imatinib or interferon alpha
Clinical Trials & Observations
Brief Report
Amy V. Jones,Richard T. Silver,Katherine Waghorn,Claire Curtis,Sebastian Kreil,Katerina Zoi,Andreas Hochhaus,David Oscier,Georgia Metzgeroth,Eva Lengfelder,Andreas Reiter,Andrew J. Chase,Nicholas C. P. Cross
PHAGOCYTES
RED CELLS
STEM CELLS IN HEMATOLOGY
TRANSPLANTATION
Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation
Clinical Trials & Observations
Angela Dispenzieri,Martha Q. Lacy,Jerry A. Katzmann,S. Vincent Rajkumar,Roshini S. Abraham,Suzanne R. Hayman,Shaji K. Kumar,Raynell Clark,Robert A. Kyle,Mark R. Litzow,David J. Inwards,Stephen M. Ansell,Ivana M. Micallef,Luis F. Porrata,Michelle A. Elliott,Patrick B. Johnston,Philip R. Greipp,Thomas E. Witzig,Steven R. Zeldenrust,Stephen J. Russell,Dennis Gastineau,Morie A. Gertz
Flow cytometric detection of circulating myeloma cells before transplantation in patients with multiple myeloma: a simple risk stratification system
Clinical Trials & Observations
David Dingli,Grzegorz S. Nowakowski,Angela Dispenzieri,Martha Q. Lacy,Suzanne R. Hayman,S. Vincent Rajkumar,Philip R. Greipp,Mark R. Litzow,Dennis A. Gastineau,Thomas E. Witzig,Morie A. Gertz
CORRESPONDENCE
Remarkable activity of novel agents bortezomib and thalidomide in patients not responding to donor lymphocyte infusions following nonmyeloablative allogeneic stem cell transplantation in multiple myeloma
Niels W. C. J. van de Donk,Nicolaus Kröger,Ute Hegenbart,Paolo Corradini,Jesus F. San Miguel,Hartmut Goldschmidt,Jose A. Perez-Simon,Mark Zijlmans,Reinier A. Raymakers,Vittorio Montefusco,Francis A. Ayuk,Marinus H. J. van Oers,Arnon Nagler,Leo F. Verdonck,Henk M. Lokhorst
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkAdvertising
- PDF Icon PDF LinkEditorial Board
Advertisement
Email alerts
Advertisement